← Back to catalogue

Lr-Act

FDA UDI

Class II (US FDA UDI)

by Medtronic, Inc.

Identity

Trade Name
LR-ACT FDA UDI
Generic Name
Heparin anti-Xa IVD, kit, chromogenic FDA UDI
Device Name
CARTRIDGE 402-01 ACT LR 13 LAN FDA UDI
Model / Reference
402-01 FDA UDI
Description
CARTRIDGE 402-01 ACT LR 13 LAN FDA UDI

Identifiers

Primary DI / UDI-DI
20763000433813 FDA UDI
FDA Product Code
JBP FDA UDI
GMDN Term
Heparin anti-Xa IVD, kit, chromogenic FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
864.7140 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Heparin anti-Xa IVD, kit, chromogenic

Lr-Act by Medtronic, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Heparin anti-Xa IVD, kit, chromogenic.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Medtronic, Inc.

Sources (1)

  • FDA UDI 74291ed7-66fb-40aa-b042-929d7791ed40 35 fields · synced Jun 8, 2026